Antigens of interest for patients with gastric cancer include CEA and ERBB2, a Phase 1 study using CEA-targeted CAR T cells in CEA positive gastric, lung, breast, pancreatic and colorectal cancer (NCT02349724) is ongoing [73]. Here, CEACAM5 is linked to gastric cancer.